Add BrightSurf on Google Email

Genetic and therapeutic landscapes in cohort of pancreatic adenocarcinomas using NGS and machine learning

A study published in Oncotarget has identified specific mutational and therapeutic landscapes of pancreatic cancer in the Russian population. By applying machine learning models to full exome individual data, researchers received personalized recommendations for targeted treatment options for each clinical case.

SourceImpact Journals LLC·JournalOncotarget·TypeExperimental study·DateFeb 14, 2024

Gene-based therapy may slow development of life-threatening heart condition

Researchers have found that a gene-based therapy targeting plakophilin-2 can interrupt the progression of arrhythmogenic right ventricular cardiomyopathy, a rare inherited disorder. The treatment reduced episodes of arrhythmia and slowed the deterioration of the heart's walls in mice.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalCirculation Genomic and Precision Medicine·TypeExperimental study·DateJan 30, 2024

Mutations in the Cu-Zn superoxide dismutase 1 gene SOD1 can cause familial amyotrophic lateral sclerosis (fALS) in a process that involves dissociation of the SOD1 dimer

A novel cyclic thiosulfinate cross-linker has favorable drug-like properties and can stabilize the SOD1 dimer in vivo, indicating potential therapeutic benefits for fALS. This study uses a mouse model to evaluate protein cross-linking as a strategy to treat SOD1 variants associated with familial ALS.

SourcePLOS·JournalPLOS Biology·DateJan 30, 2024

Using fMRI, new vision study finds promising model for restoring cone function

Researchers used fMRI to assess brain responses to lights stimulating only cone cells in dogs with different types of retinal diseases. The study found that gene augmentation therapy restored response in cortex to black and white stimulation, making this disease a promising one for photoreceptor cell replacement treatment.

SourceUniversity of Pennsylvania·JournalTranslational Vision Science & Technology·TypeExperimental study·DateJan 26, 2024

Gene therapy restores hearing in children with hereditary deafness

A novel gene therapy has been shown to restore hearing function in six children with DFNB9, a form of autosomal recessive deafness. The treatment, which uses an adeno-associated virus carrying a version of the human OTOF gene, demonstrated significant improvements in speech perception and ability to conduct normal conversation.

SourceMass Eye and Ear·JournalThe Lancet·TypeExperimental study·DateJan 24, 2024

Older adults spend 3 weeks each year receiving health care outside of the home

A cross-sectional study of over 6,500 adults aged 65+ found that older adults spent an average of 20.7 days per year receiving healthcare outside the home. The 'health care contact days' metric can help evaluate care and identify areas for improvement, such as coordinating tests with visits and reducing Friday office visits.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateJan 22, 2024

Researchers identify key characteristics associated with improved CAR T outcomes in large B cell lymphoma

Researchers identified key characteristics associated with improved CAR T outcomes in large B cell lymphoma, including a B-cell gene expression signature and high CD19 protein expression. Patients who received axicabtagene ciloleucel had better event-free survival compared to those receiving standard therapy.

SourceH. Lee Moffitt Cancer Center & Research Institute·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateJan 17, 2024

New gene therapy could significantly reduce seizures in severe childhood epilepsy

Researchers at UCL Queen Square Institute of Neurology have developed a new gene therapy that significantly reduces seizures in mice with focal cortical dysplasia. The treatment, which involves the overexpression of a potassium channel, has shown an average reduction of 87% in seizures without affecting the mouse's memory or behavior.

SourceUniversity College London·JournalBrain·TypeExperimental study·DateDec 14, 2023

A participant from Queen Mary University of London Genes & Health study is the 10th person enrolled in a gene-editing clinical trial for heart disease

The Genes & Health study has enrolled its 10th participant in a gene-editing clinical trial for heart disease, specifically familial hypercholesterolemia. This milestone marks an important step towards improving health outcomes for people of Pakistani and Bangladeshi descent.

SourceQueen Mary University of London·TypeRandomized controlled/clinical trial·DateNov 12, 2023

Team looking at gene therapy for children paralyzed by rare mutations

Researchers at the University of Texas Health Science Center discovered a gene therapy approach that can restore motor functions in mice with Contactin-Associated Protein 1 (Cntnap1) mutations. The study found that turning on the normal gene earlier improves the rescue outcome, and the next phase is to test this approach in humans.

SourceUniversity of Texas Health Science Center at San Antonio·JournalCell Reports·TypeExperimental study·DateOct 20, 2023

3D genome architecture influences SCID-X1 gene therapy success

Researchers identified the integration site pattern of lentiviral gene therapies in patient cells, shedding light on treatment safety and efficacy. The study found that integration near nuclear pores is associated with improved safety and effectiveness, avoiding oncogene regions where earlier technologies failed.

SourceSt. Jude Children's Research Hospital·JournalScience Advances·TypeRandomized controlled/clinical trial·DateOct 6, 2023

Ultrasound enables gene delivery throughout the brain

Researchers at Rice University have developed a non-invasive gene delivery technique using ultrasound to efficiently deliver clinically used gene therapy vectors throughout the brain. The study, published in Gene Therapy, shows that opening more sites within targeted regions improves gene delivery efficiency.

SourceRice University·JournalGene Therapy·TypeExperimental study·DateSep 27, 2023

St. Jude refines definition and hones treatment of hyperdiploid leukemia

Researchers at St. Jude Children's Research Hospital refined the definition of hyperdiploidy in childhood B-cell acute lymphoblastic leukemia (B-ALL), using DNA index to predict patient outcomes. The study found that a simpler system captures a significant proportion of patients with excellent prognoses, and that individual chromosome ...

SourceSt. Jude Children's Research Hospital·JournalJournal of Clinical Oncology·DateSep 20, 2023

Gene therapy for brain tumor shows promising early results in humans

A new study from the University of Michigan Department of Neurosurgery and Rogel Cancer Center shows promising early results that a therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending survival for patients with gliomas, a highly aggressive form of brain cancer. The treatment improved survival...

SourceMichigan Medicine - University of Michigan·JournalThe Lancet Oncology·TypeRandomized controlled/clinical trial·DateAug 31, 2023

New study shows promising evidence for sickle cell gene therapy

A new clinical trial published in the New England Journal of Medicine indicates that stem cell gene therapy may offer a promising, curative treatment for sickle cell disease. The therapy was shown to decrease vaso-occlusive events and increase production of fetal hemoglobin, providing relief from the painful condition.

SourceUniversity of Chicago Medical Center·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateAug 30, 2023

The efficacy of gene therapy demonstrated in patients suffering from Crigler-Najjar Syndrome, a rare liver disease

A European gene therapy clinical trial has demonstrated the possibility of restoring expression of the UGT1A1 enzyme in patients with severe Crigler-Najjar syndrome. The treatment resulted in significant reduction in bilirubin levels and sustained efficacy in patients, offering a new hope for treating this rare metabolic disease.

SourceAFM-Téléthon·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateAug 17, 2023

Genetically modified neural stem cells developed by CityU and HKUMed researchers show promising therapeutic potential for spinal cord injury

Researchers at CityU and HKUMed developed genetically modified human neural stem cells that promote neural circuit reconstruction, reduce glial scar accumulation, and enhance axon outgrowth. The therapy demonstrates potential for treating severe spinal cord injuries with functional recovery.

SourceCity University of Hong Kong·JournalAdvanced Science·TypeExperimental study·DateAug 16, 2023

Gene therapy may offer a new treatment strategy for alcohol use disorder

Researchers have discovered that gene therapy may prevent relapse in patients with serious alcohol addiction by altering dopamine function in the brain's mesolimbic reward pathway. The treatment involves sustained release of glial-derived neurotrophic factor (GDNF) in a specific region of the brain.

SourceOhio State University Wexner Medical Center·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateAug 14, 2023

Study shows promise of gene therapy for alcohol use disorder

Researchers at Oregon Health & Science University have found that implanting a specific molecule in the brain can effectively reduce alcohol use among chronic heavy drinkers. The study showed a 90% reduction in drinking behavior in nonhuman primates, with the implanted virus permanently increasing dopamine levels and reducing cravings.

SourceOregon Health & Science University·JournalNature Medicine·TypeExperimental study·DateAug 14, 2023

Researchers reverse hearing loss in mice

A study published in Proceedings of the National Academy of Sciences successfully reversed hearing loss in mice by activating a defective gene. The researchers found that introducing a special enzyme at a young age significantly improved hearing, with positive effects becoming less potent with time.

SourceKing's College London·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateAug 10, 2023

Gene therapy treats chronic pain by dialing down sodium

Researchers at NYU College of Dentistry developed a gene therapy that regulates sodium ion channel activity to alleviate chronic pain. By targeting the specific region where CRMP2 binds to NaV1.7, they were able to reduce sodium influx and quiet down neurons, providing relief from pain in cell and animal studies.

SourceNew York University·JournalProceedings of the National Academy of Sciences·DateJul 27, 2023